Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program

Animal studies have demonstrated that metformin exerts a renoprotective effect. Human studies of patients with diabetes mellitus (DM) regarding the association of metformin use with end-stage renal disease (ESRD) are lacking. Patients with type 2 DM and without a history of kidney disease who were e...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical pharmacology Vol. 59; no. 11; p. 1443
Main Authors Lee, Ming-Chia, Lee, Chih-Hsin, Chang, Lih-Yu, Chang, Chia-Hao, Zhang, Jun-Fu, Lee, Meng-Rui, Wang, Jann-Yuan, Chen, Shih-Ming
Format Journal Article
LanguageEnglish
Published England 01.11.2019
Subjects
Online AccessGet more information

Cover

Loading…